Filing Flows › Macerich (MAC) › Guidance & outlook
Macerich (MAC) guidance and outlook
Macerich's 10-Q filed Nov 5, 2026 makes 32 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 5, 2026
- The Company anticipates future additional properties will be added to the facility borrowing base, as defined, that would allow the Company to borrow up to $550 million.
- The total cost of the project is estimated to be between $84.0 million and $90.0 million, with $42.0 million to $45.0 million estimated to be the Company’s pro rata share.
- The total cost of the project is estimated to be between $245.0 million and $265.0 million, with $125.0 million to $135.0 million estimated to be the Company’s pro rata share.
- On November 2, 2026, the Company announced a fourth quarter cash dividend of $0.17 per share of its common stock, which will be paid on December 28, 2026 to stockholders of record on December 14, 2026.
- The Company expects to physically settle the forward sale agreements and receive proceeds, subject to certain adjustments, from the sale of those shares of its common stock upon one or more such physical settlements no later than June 16, 2027.
- Although the Company expects to settle the forward sale agreements entirely by the physical delivery of shares of its common stock for cash proceeds, the Company may also elect to cash settle or net share settle all or a portion of its obligations under the forward sale agreements, in which case, the Company may not receive any proceeds, and the Company may owe cash or shares of its common stock to the forward…
- The exchangeable senior notes will be redeemable, in whole or in part (subject to certain limitations), for cash at the Operating Partnership’s option at any time, and from time to time, on or after August 20, 2029 and on or before the 41st scheduled trading day immediately before the maturity date, but only if the last reported sale price per share of the Company’s common stock exceeds 130% of the exchange price…
- The capped call transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any exchange of exchangeable senior notes and/or offset any cash payments the Operating Partnership is required to make in excess of the principal amount of exchanged notes, as the case may be, with such reduction and/or offset subject to a cap.
- See “Liquidity and Capital Resources” for a further discussion of the Company’s anticipated liquidity needs, and the measures taken by the Company to meet those needs.
- Inflation had a negative impact on the Company's costs in 2025 and is expected to have a negative impact on the Company's costs for the remainder of 2026.
- The Company assesses whether an indicator of impairment in the value of its properties exists by considering expected future operating income, trends and prospects, as well as the effects of demand, competition and other economic factors.
- Changes in events or changes in circumstances may alter the expected hold period of an asset or asset group, which may result in an impairment loss and such loss could be material to the Company’s financial condition or operating performance.
Macerich's latest quarter
Macerich, Q3 2026: revenue $260M (+3% year over year), operating margin -14.5%, net loss $16.1M, operating cash flow $109M. The chart follows the revenue to costs, profit and cash.
Questions
What does Macerich expect?
The Company anticipates future additional properties will be added to the facility borrowing base, as defined, that would allow the Company to borrow up to $550 million. The total cost of the project is estimated to be between $84.0 million and $90.0 million, with $42.0 million to $45.0 million estimated to be the Company’s pro rata share. The total cost of the project is estimated to be between $245.0 million and $265.0 million, with $125.0 million to $135.0 million estimated to be the Company’s pro rata share.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.